BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9152376)

  • 1. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine.
    Bhargava HN; Bian JT; Kumar S
    J Pharmacol Exp Ther; 1997 May; 281(2):707-12. PubMed ID: 9152376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N(G)-nitro-L-arginine reverses L-arginine induced changes in morphine antinociception and distribution of morphine in brain regions and spinal cord of the mouse.
    Bhargava HN; Bian JT
    Brain Res; 1997 Feb; 749(2):351-3. PubMed ID: 9138738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of [D-Pen2, D-Pen5] enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
    Bhargava HN; Cao YJ
    Peptides; 1998; 19(1):113-7. PubMed ID: 9437743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
    Bhargava HN; Cao YJ
    Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spinal nitric oxide involved in the inhibitory effect of midazolam on morphine-induced analgesia tolerance.
    Cao JL; Ding HL; He JH; Zhang LC; Duan SM; Zeng YM
    Pharmacol Biochem Behav; 2005 Mar; 80(3):493-503. PubMed ID: 15740792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Gen Pharmacol; 1993 Nov; 24(6):1351-7. PubMed ID: 8112506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
    Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
    Xu JY; Hill KP; Bidlack JM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):196-201. PubMed ID: 9435178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute administration of L-arginine on morphine antinociception and morphine distribution in central and peripheral tissues of mice.
    Bhargava HN; Bian JT
    Pharmacol Biochem Behav; 1998 Sep; 61(1):29-33. PubMed ID: 9715804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
    Galeote L; Kieffer BL; Maldonado R; Berrendero F
    J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
    Ohlsson AE; Fu TC; Jones D; Martin BR; Dewey WL
    J Pharmacol Exp Ther; 1982 May; 221(2):362-7. PubMed ID: 6281413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
    Abrahao KP; Quadros IM; Souza-Formigoni ML
    Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.